EUCTR2014-004761-25-FI进行中（未招募）不适用
Incretin-based therapy in late preclinical type 1 diabetes - LiraAABDG10-30
Riitta Veijola0 个研究点目标入组 82 人开始时间: 2015年12月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The subjects are 10-30 years of age, positive for at least 2 betacell specific autoantibodies, have dysglycemia in OGTT (e.g. impaired glucose tolerance or impaired fasting glucose) or increasing HbA1c (at least 10% increase between two HbA1c measurements or HbA1c at least 5.9% in two measurements), and are not pregnant.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 41
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 41
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Principal exclusion criteria are:
- •type 1 diabetes
- •previous treatment in the last three months with any antidiabetic medication
- •impaired liver or kidney function
- •past or current history of pancreatitis
- •serum calcitonin value above normal (>50 ng/l)
- •presence of any chronic metabolic, hematologic or malignant disease
- •obesity BMI =30 or ISO-BMI =30 (Cole et al. 2000)
- •pregnancy
研究者
相似试验
进行中（未招募）
不适用
Incretin-based therapy in preclinical type 1 diabetes in adults.MedDRA version: 18.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 diabetesEUCTR2014-003667-37-FIRiitta Veijola
进行中（未招募）
不适用
Incretin-based therapy in non-symptomatic, early diagnosed type 1 diabeticsType 1 diabetesEUCTR2014-004760-37-FIRiitta Veijola10
已完成
2 期
Incretin-based Therapy in Late Preclinical Type 1 DiabetesType 1 DiabetesNCT02898506University of Oulu13
已完成
2 期
Incretin-based Therapy in Early Diagnosed Type 1 DiabetesType 1 DiabetesNCT02908087University of Oulu13
进行中（未招募）
不适用
GLP-1 analogs for Freidreich's Ataxia treatment.EUCTR2014-003598-41-BECUB - Hôpital Erasme